首页 > 市场调查报告书 > 製药

药物开发以基因为基之药物开发人工智能人工智能药物研发

市场调查报告书

商品编码

1079540

基因组学中的全球人工智能市场

Artificial Intelligence (AI) in Genomics: Global Market

出版日期: 2022年05月26日 | 出版商:

BCC Research | 英文 104 Pages | 订单完成后即时交付

价格

简介目录图表

全球基因组学中人工智能市场的规模预计将从 2021 年的 4.986 亿美元增长到预测期内的 47.3% 的复合年增长率，到 2027 年将超过 48 亿美元。

按地区划分，北美地区预计将从 2021 年的 2.186 亿美元增长到预测期内的 44.8%，并在 2027 年超过 19 亿美元。亚太地区预计将从 2021 年的 1.203 亿美元增长到 2027 年的 13 亿美元以上，增长 50.5%。

本报告探讨了全球基因组学中的 AI 市场，分析了市场和技术背景、冠状病毒感染（COVID-19）等市场影响因素、市场规模趋势和预测，总结了各个类别/地区/主要国家、相关法律法规、专利趋势、竞争环境、主要公司概况等。

Highlights:

The global market for AI in genomics reached $498.6 million in 2021 and should reach more than $4.8 billion in 2027, with a compound annual growth rate (CAGR) of 47.3% during the forecast period of 2021-2027.

North American market reached $218.6 million in 2021 and should reach more than $1.9 billion in 2027 with a (CAGR) of 44.8% during the forecast period of 2021-2027.

Asia-Pacific market reached $120.3 million in 2021 and should reach more than $1.3 billion in 2027 with a (CAGR) of 50.5% during the forecast period of 2021-2027.

Report Scope:

This report highlights the current and future market potential for AI genomics and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities, and trends in the market. The report also covers market projections through 2027 as well as key market players. BCC Research analyzes each technology in detail, determines major players and current market

status, and presents forecasts of growth over the next five years. Scientific challenges and advances, including the latest trends, are emphasized. Government regulations, major collaborations, recent patents, and factors affecting the industry from a global perspective are examined.

Key AI in genomics technologies and products are analyzed to determine present and future market status, and growth is forecast from 2022 to 2027. An in-depth discussion of strategic alliances, industry structures, competitive dynamics, patents, and market driving forces are also provided.

Report Includes:

23 data tables and 19 additional tables
An overview of the global market for artificial intelligence (AI) in genomics applications
Analyses of the global market trends, with revenue data from 2020-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
Highlights of the current and future market potential for the AI genomics industry with an emphasis on new products and technologies, and areas of focus to forecast this market into various segments and sub-segments
Evaluation and forecast the global AI genomics market size, and corresponding market share analysis by technology, offerings, application, and geographic region
Technology assessment of the key drivers, restraints and opportunities that will shape the market for AI in genomics over the forecast period (2021 to 2027)
In-depth information on major technology issues and challenges, government regulations, breakthrough innovations, collaborations and developments, and costs and benefits of AI applications in the genomics industry
Review of recent industry trends, R&D activities, competitive landscape featuring key market participants, and COVID-19 implications within the AI genomics market ecosystem
Company profiles of major players, including BenevolentAI, Data4Cure Inc., Deep Genomics, IBM Corp., and Microsoft Corp.

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing the Study
Intended Audience
Scope and Format
Methodology
Information Sources
Geographical Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Overview

Introduction to Artificial Intelligence
Understanding Artificial Intelligence in Healthcare
Artificial Intelligence in Healthcare Evolution and Transition
Introduction to Genomics
Artificial Intelligence (AI) Analysis
Software Development

Chapter 4 Impact of the COVID-19 Pandemic

Introduction
Impact of COVID-19 on the Market
Impact on MedTech
Changes in Consumption Trends for Health-Related Products

Chapter 5 Market Dynamics

Market Drivers
Investment in AI Health Sector
Increasing Strategic Moves by Market Players and Governments
Increasing Incidences of Chronic Disease
Demand for Personalized Medicine
Increasing Research and Development Budget
Restraints and Challenges
Reluctance Among Medical Practitioners to Adopt AI-Based Technologies
Ambiguous Regulatory Guidelines for Medical Software
Challenge to Maintain Data Security
Opportunities
Untapped Potential in Emerging Markets

Chapter 6 Market Breakdown by Offering

Software
Market Size and Forecast
Services
Market Size and Forecast

Chapter 7 Market Breakdown by Technology

Machine Learning
Market Size and Forecast
Computer Vision
Market Size and Forecast

Chapter 8 AI in Genomics by Application

Diagnostics
Market Size and Forecast
Drug Discovery and Development
Process of Drug Discovery
History of Drug Discovery
Classification of Techniques Used in Drug Discovery
Market Size and Forecast
Others
Market Size and Forecast

Chapter 9 Market Breakdown by Region

Global Market for AI in Genomics by Region
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World

Chapter 10 Regulations and Finance

Regulatory Framework
American Diabetes Association's Standards of Medical Care in Diabetes
ATA Guidelines for Artificial Intelligence
Indian AI Guidelines, Strategy, and Standards

Chapter 11 Patent Review

Chapter 12 Competitive Landscape

Overview

Recent Developments

Chapter 13 Company Profiles

BENEVOLENTAI
DATA4CURE INC.
DEEP GENOMICS
DNANEXUS INC.
FDNA INC.
GENOOX
INTERNATIONAL BUSINESS MACHINES CORP. (IBM)
LIFEBIT
MICROSOFT CORP.
NVIDIA
SOPHIA GENETICS

简介目录图表

List of Tables

Summary Table : Global Market for AI in Genomics, by Region, Through 2027
Table 1 : Cancer Statistics Across Major Asian Countries, by Cancer Site/Type, 2020
Table 2 : Global Market for AI in Genomics, by Offering, Through 2027
Table 3 : Global Market for AI in Genomics, by Technology, Through 2027
Table 4 : Global Market for AI in Genomics, by Application, Through 2027
Table 5 : History of Drug Discovery
Table 6 : Global Market for AI in Genomics, by Region, Through 2027
Table 7 : North American Market for AI in Genomics, by Offering, Through 2027
Table 8 : North American Market for AI in Genomics, by Technology, Through 2027
Table 9 : North American Market for AI in Genomics, by Application, Through 2027
Table 10 : North American Market for AI in Genomics, by Country, Through 2027
Table 11 : European Market for AI in Genomics, by Offering, Through 2027
Table 12 : European Market for AI in Genomics, by Technology, Through 2027
Table 13 : European Market for AI in Genomics, by Application, Through 2027
Table 14 : European Market for AI in Genomics, by Country, Through 2027
Table 15 : Asia-Pacific Market for AI in Genomics, by Offering, Through 2027
Table 16 : Asia-Pacific Market for AI in Genomics, by Technology, Through 2027
Table 17 : Asia-Pacific Market for AI in Genomics, by Application, Through 2027
Table 18 : Asia-Pacific Market for AI in Genomics, by Country, Through 2027
Table 19 : Number of New Cancer Cases in Japan in Both Sexes, 2020
Table 20 : Rest of the World Market for AI in Genomics, by Offering, Through 2027
Table 21 : Rest of the World Market for AI in Genomics, by Technology, Through 2027
Table 22 : Rest of the World Market for AI in Genomics, by Application, Through 2027
Table 23 : Regulations Pertaining AI Genomics in Select Countries
Table 24 : Analysis of Patents Related to AI in Genomics
Table 25 : Leading Market Players in the AI Genomics Market Ecosystem
Table 26 : BenevolentAI: Product Portfolio
Table 27 : Data4Cure: Product Portfolio
Table 28 : Deep Genomics: Product Portfolio
Table 29 : DNAnexus: Product Portfolio
Table 30 : FDNA Inc.: Product Portfolio
Table 31 : Genoox: Product Portfolio
Table 32 : IBM Corp.: Company Financials, 2020 and 2021
Table 33 : IBM: Product Portfolio
Table 34 : IBM Corp.: Company Strategic Developments, 2017-2019
Table 35 : Lifebit: Product Portfolio
Table 36 : Microsoft Corp.: Financials, 2019-2021
Table 37 : Microsoft Corp.: Product Portfolio
Table 38 : Microsoft Corp.: Strategies and Developments
Table 39 : Nvidia: Company Financials, 2019 and 2020
Table 40 : Nvidia: Product Portfolio
Table 41 : SOPHiA GENETICS: Product Portfolio

List of Figures

Summary Figure A : Global AI In Genomics Market, by Region, 2020-2027
Summary Figure B : Global Market Shares of AI in Genomics, by Region, 2021
Figure 1 : Global Funding in Health-Tech Companies
Figure 2 : Global Projections of Deaths from the Top Three Chronic Diseases, 2005-2030
Figure 3 : Increased Incidence of Cancer, 2012 and 2030
Figure 4 : Global Distribution of Deaths from Chronic Diseases, 2019
Figure 5 : Funding for Disease Research, 2014-2018
Figure 6 : Rising Trends in Healthcare Spending, by Institution, 2015-2035
Figure 7 : Global Market Shares of AI in Genomics, by Offering, 2021
Figure 8 : Global Market for AI in Genomics, by Offering, 2020-2027
Figure 9 : Global Market for Software in Software in an AI Systems, 2020-2027
Figure 10 : Global Market for AI Services, 2020-2027
Figure 11 : Global Market Shares of AI in Genomics, by Technology, 2021
Figure 12 : Global Market for AI in Genomics, by Technology, 2020-2027
Figure 13 : Global Market for Machine Learning, 2020-2027
Figure 14 : Global Market for Computer Vision, 2020-2027
Figure 15 : Global Market Shares of AI in Genomics, by Application, 2021
Figure 16 : Global Market for AI in Genomics, by Application, 2020-2027
Figure 17 : Global Market for AI in Diagnostics, 2020-2027
Figure 18 : Process of Drug Discovery
Figure 19 : Global Market for AI in Drug Discovery and Development, 2020-2027
Figure 20 : Global Market for Other Applications of AI in Genomics, 2020-2027
Figure 21 : Global Market Shares of AI in Genomics, by Region, 2021
Figure 22 : North American Market Shares of AI in Genomics, by Offering, 2021
Figure 23 : North American Market Shares of AI in Genomics, by Technology, 2021
Figure 24 : North American Market Shares of AI in Genomics, by Application, 2021
Figure 25 : North American Market Shares of AI in Genomics, by Country, 2021
Figure 26 : U.S. Market for AI in Genomics, 2020-2027
Figure 27 : Canadian Market for AI in Genomics, 2020-2027
Figure 28 : European Market Shares of AI in Genomics, by Offering, 2021
Figure 29 : European AI Genomics Market Shares, by Technology, 2021
Figure 30 : European Market Shares of AI in Genomics, by Application, 2021
Figure 31 : European Market Shares of AI in Genomics, by Country, 2021
Figure 32 : Geriatric Population in Germany, 2000-2030
Figure 33 : German Market for AI in Genomics, 2020-2027
Figure 34 : U.K. Market for AI in Genomics, 2020-2027
Figure 35 : French Market for AI in Genomics, 2020-2027
Figure 36 : Italian Market for AI in Genomics, 2020-2027
Figure 37 : Spanish Market for AI in Genomics, 2020-2027
Figure 38 : Rest of Europe Market for AI in Genomics, 2020-2027
Figure 39 : Asia-Pacific Market Shares of AI in Genomics, by Offering, 2021
Figure 40 : Asia-Pacific Market Shares of AI in Genomics, by Technology, 2021
Figure 41 : Asia-Pacific Market Shares of AI in Genomics, by Application, 2021
Figure 42 : Asia-Pacific Market Shares of AI in Genomics, by Country, 2021
Figure 43 : New Cancer Cases in China, 2020
Figure 44 : Distribution of New Cancer Cases in China, 2020
Figure 45 : Chinese Market for AI in Genomics, 2020-2027
Figure 46 : Japanese Market for AI in Genomics, 2020-2027
Figure 47 : Indian Market for AI in Genomics, 2020-2027
Figure 48 : Rest of Asia-Pacific Market for AI in Genomics, 2020-2027
Figure 49 : New Cancer Cases in Africa, 2020
Figure 50 : Rest of the World Market Shares of AI in Genomics, by Offering, 2021
Figure 51 : Rest of the World Market Shares of AI in Genomics, by Technology, 2021
Figure 52 : Rest of the World Market Shares of AI in Genomics, by Application, 2021
Figure 53 : Microsoft Corp.: Revenue Share, by Region/Country, 2021